| HF | heart failure |
| HFrEF | heart failure with reduced ejection fraction |
| HFpEF | heart failure with preserved ejection fraction |
| GDMT | guideline-directed medical therapy |
| SGLT2i | sodium–glucose cotransporter 2 inhibitors |
| ASCs | adult stem cells |
| MSCs | mesenchymal stem cells |
| BM-MSCs | bone-marrow-derived mesenchymal stem cells |
| UC-MSCs | umbilical cord-derived mesenchymal stem cells |
| LVEF | left ventricular ejection fraction |
| QoL | quality of life |
| AHA | American Heart Association |
| RCTs | randomized controlled trials |
| CPCs | cardiosphere-derived cells |
| MI | myocardial infarction |
| IC | intracoronary |
| IM | intramyocardial |
| MRI | magnetic resonance imaging |
| NYHA* | New York heart association |
| CABG** | coronary artery bypass graft |
| PCI*** | percutaneous coronary intervention |
| STEMI**** | ST-elevation myocardial infarction |